TGFB1 and type 2 diabetes mellitus: At 7 days, still in relation to TGFβ, moderate labeling (+++) was observed in the inflammatory cells in the socket of NG group, and intense labeling (++++) in the inflammatory cells in the alveolar bone of T2D group (Figure 4; Table 4).